HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care

KMK HEOR Principal Huanxue Zhou‘s latest manuscript, Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses, was published in the International Journal of MS Care. A PDF of the article is available for download. BACKGROUND Clinical and real-world studies have shown significant reductions in MS relapses in patients receiving fingolimod versus […]

Real World Evidence to Support Payer Negotiation

How do you prove a product’s value to negotiate pricing with a payer?  Our client, a large global pharmaceutical company, was facing a market access problem for their newly launched product. Generic treatments have been widely available for many years in this particular therapeutic category. Although the efficacy of our client’s product has been demonstrated […]